Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature
CA 2418097 A1 · Owner: Salois, Patrick · Inventors: Moffat, Pierre; Salois, Patrick; Lanctot, Christian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to the use of a virus or of a vital genome for screening/selecting exogenous nucleic acids having a desired feature. Mare particularly the present invention provides a , dysfunctional viral genome capable of both expressing libraries of exogenous nucleic acids and selecting the sequences having a predefined characteristic or function within the cell such, as as nucleic acids encoding signal peptides secreted proteins, membrane , bound proteins proteases, protease cleaving site and drugresistance proteins. The invention further provides methods and kits for selecting nucleic acids having a desired feature. According to one embodiment, production of a viral particle …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 17, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 17, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 17, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.